Amylin's Ohio Plant Had Inappropriate Quality Control, Fda Says
Source: Business Week
Friday 12th March, 2010
March 12 (Bloomberg) -- Amylin Pharmaceuticals Inc.'s Cincinnati manufacturing plant didn't have procedures to prevent contamination or trained employees in a December inspection, accordin... ...
Read the full story at
Business Week
Email this story to a friend
Have your say on this story
